LifeStance Health Group (LFST) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Reported EPS
- $0.11
- Estimate
- $0.08
- Surprise
- +32.4%
- Revenue (period 2026-06-30)
- $435.4M
- Score at report (before → after)
- 5.4 → 5.6/10
Revenue source: xbrl.
How the report landed
LifeStance Health Group (LFST) beat the $0.08 estimate with diluted EPS of $0.11 — a large 32.4% upside surprise. TrendMatrix's engine moved from Sell (5.4/10) to Hold at 5.6/10 after the report.
Where TrendMatrix's rating stands now
TrendMatrix currently rates LFST Hold at 5.6/10.
3 of the last 4 quarters beat the estimate; this quarter's +32.4% surprise compares with a +10.9% four-quarter average. Next scheduled report: 2026-11-05.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Strong earnings beat streak (3/4)
What argues against it
- Analyst target reached - limited upside remaining
- Near 52-week high (2.3% away)
- V7 low-quality RISK_OFF penalty: -0.5 (Q=4.4)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $13.00
- Price target
- $14.92
- Stop
- $12.09
- Upside to target
- +14.8%
The stock trades at 99.8× trailing but 24.4× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: trading volume is running 1.7× its average — elevated turnover around the report window.
Model outputs from TrendMatrix’s engine as of 2026-09-14 — shown for context, not personalized investment advice.
LFST at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Care Facilities
- Market cap
- $4.96B
- P/E (fwd)
- 24.4
- P/E (ttm)
- 99.8
- 52-week range
- $4.77–$13.28
- Off 52-week high
- 2.1%
- RSI (14)
- 62
- Volume vs avg
- 1.70×
- Score today
- 5.6/10